New injection aims to ease breathing in cancer patients with Fluid-Filled lungs

NCT ID NCT07649369

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug, JMKX000197, against a standard chemotherapy drug (cisplatin) to see which works better at controlling fluid buildup around the lungs in people with advanced cancer. About 120 participants with moderate to large fluid collections will receive the drug directly into the chest cavity. The goal is to reduce the need for drainage and improve comfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL EFFUSIONS (MPE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cancer Hospital, Chinese Academy of Medical Sciences

    Beijing, 100017, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.